Business
HEALWELL Achieves Record Q3 Revenue Growth Now as a Pure-Play Global SaaS, Services & AI Company for Health Systems and Life Sciences
HEALWELL achieved quarterly revenue from continuing operations of $30.4 million in Q3-2025, an in...
About this update from Healwell Ai Inc. Class A
[{"type":"text","content":"HEALWELL Achieves Record Q3 Revenue Growth Now as a Pure-Play Global SaaS, Services & AI Company for Health Systems and Life SciencesHEALWELL achieved quarterly revenue from continuing operations of $30.4 million in Q3-2025, an increase of 354% compared to revenue of $6.7 million generated in Q3-2024. Revenue growth in the quarter was largely driven by the Orion Health acquisition.During Q3-2025, HEALWELL reported positive Adjusted EBITDA of $0.7 million, compared to an Adjusted EBITDA loss of $2.8 million in Q3-2024. This marks the Company's second consecutive quarter of positive Adjusted EBITDA, highlighting continued execution improvements and stronger financial performance. During Q3-2025, the Company's IFRS net loss from continuing operations was $16.0 million compared to a net loss of $8.7 million for the previous year. During Q3-2025, HEALWELL acquired the remaining 49% interest in Pentavere Research Group Inc., gaining full ownership of the AI company and strengthening its AI segment with Pentavere's DARWEN™ platform for early disease detection.Subsequent to the end of the quarter, HEALWELL completed a series of strategic divestments, including the sale of its Polyclinic Family Medicine and Specialty Clinics, the sale of its majority interest in Mutuo Health Solutions, and the formation of a 50/50 clinical research joint venture with WELL Health Technologies Corp. Toronto, Ontario--(Newsfile Corp. - November 6, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) (\"HEALWELL\" or the \"Company\"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce its unaudited interim condensed consolidated financial results for the quarter ended September 30, 2025. A summary of the Company's financial and operational results is set out below, and more detailed information is contained in the interim financial statements and related management discussion and analysis, which are available on the Company's SEDAR+ page at www.sedarplus.com. Financial measures described as \"Adjusted\" in this news release are non-IFRS financial measures and may not be comparable to other similar measures disclosed by other companies. Please see Non-IFRS Financial Measures below for more information.James Lee, Chief Executive Officer of HEALWELL, commented, \"We are pleased to report HEALWELL's ...